Research ArticleArticle
Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review
Helen Twohig, Claire Owen, Sara Muller, Christian D. Mallen, Caroline Mitchell, Samantha Hider, Catherine Hill, Beverley Shea and Sarah Mackie
The Journal of Rheumatology August 2020, jrheum.200248; DOI: https://doi.org/10.3899/jrheum.200248
Helen Twohig
This work was supported by a Wellcome Trust PhD Programme for Primary Care Clinicians [203921/Z/16/Z], which supports Helen Twohig. CDM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHRRP- 2014-04-026). The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. 1H. Twohig, MRCP, MRCGP, S. Muller, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK; 2C. Owen, MBBS (Hons), FRACP, Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Melbourne, Australia; 3C.D. Mallen, FRCGP, PhD, S. Hider, FRCP, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, and Midlands Partnership Foundation Trust, Staffordshire, UK; 4C. Mitchell, FRCGP, MD, Academic Department of Primary Medical Care, University of Sheffield, Sheffield, UK; 5C. Hill, FRACP, MD, Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, and Discipline of Medicine, The University of Adelaide, Adelaide, Australia; 6B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 7S.L. Mackie, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Woodhouse, Leeds, UK. S.L. Mackie declares consultancy to Roche, Chugai, and Sanofi on behalf of University of Leeds (no money paid to her directly in last 3 years); Patron of PMRGCAuk; current or recent site investigator on clinical trials for GSK and Sanofi; and EULAR2019 attendance supported by Roche. S. Muller is a trustee of PMRGCAuk. Address correspondence to Dr. H. Twohig, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK. Email: h.j.twohig@keele.ac.uk. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication July 13, 2020.
Claire Owen
This work was supported by a Wellcome Trust PhD Programme for Primary Care Clinicians [203921/Z/16/Z], which supports Helen Twohig. CDM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHRRP- 2014-04-026). The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. 1H. Twohig, MRCP, MRCGP, S. Muller, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK; 2C. Owen, MBBS (Hons), FRACP, Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Melbourne, Australia; 3C.D. Mallen, FRCGP, PhD, S. Hider, FRCP, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, and Midlands Partnership Foundation Trust, Staffordshire, UK; 4C. Mitchell, FRCGP, MD, Academic Department of Primary Medical Care, University of Sheffield, Sheffield, UK; 5C. Hill, FRACP, MD, Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, and Discipline of Medicine, The University of Adelaide, Adelaide, Australia; 6B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 7S.L. Mackie, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Woodhouse, Leeds, UK. S.L. Mackie declares consultancy to Roche, Chugai, and Sanofi on behalf of University of Leeds (no money paid to her directly in last 3 years); Patron of PMRGCAuk; current or recent site investigator on clinical trials for GSK and Sanofi; and EULAR2019 attendance supported by Roche. S. Muller is a trustee of PMRGCAuk. Address correspondence to Dr. H. Twohig, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK. Email: h.j.twohig@keele.ac.uk. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication July 13, 2020.
Sara Muller
This work was supported by a Wellcome Trust PhD Programme for Primary Care Clinicians [203921/Z/16/Z], which supports Helen Twohig. CDM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHRRP- 2014-04-026). The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. 1H. Twohig, MRCP, MRCGP, S. Muller, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK; 2C. Owen, MBBS (Hons), FRACP, Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Melbourne, Australia; 3C.D. Mallen, FRCGP, PhD, S. Hider, FRCP, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, and Midlands Partnership Foundation Trust, Staffordshire, UK; 4C. Mitchell, FRCGP, MD, Academic Department of Primary Medical Care, University of Sheffield, Sheffield, UK; 5C. Hill, FRACP, MD, Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, and Discipline of Medicine, The University of Adelaide, Adelaide, Australia; 6B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 7S.L. Mackie, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Woodhouse, Leeds, UK. S.L. Mackie declares consultancy to Roche, Chugai, and Sanofi on behalf of University of Leeds (no money paid to her directly in last 3 years); Patron of PMRGCAuk; current or recent site investigator on clinical trials for GSK and Sanofi; and EULAR2019 attendance supported by Roche. S. Muller is a trustee of PMRGCAuk. Address correspondence to Dr. H. Twohig, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK. Email: h.j.twohig@keele.ac.uk. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication July 13, 2020.
Christian D. Mallen
This work was supported by a Wellcome Trust PhD Programme for Primary Care Clinicians [203921/Z/16/Z], which supports Helen Twohig. CDM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHRRP- 2014-04-026). The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. 1H. Twohig, MRCP, MRCGP, S. Muller, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK; 2C. Owen, MBBS (Hons), FRACP, Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Melbourne, Australia; 3C.D. Mallen, FRCGP, PhD, S. Hider, FRCP, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, and Midlands Partnership Foundation Trust, Staffordshire, UK; 4C. Mitchell, FRCGP, MD, Academic Department of Primary Medical Care, University of Sheffield, Sheffield, UK; 5C. Hill, FRACP, MD, Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, and Discipline of Medicine, The University of Adelaide, Adelaide, Australia; 6B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 7S.L. Mackie, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Woodhouse, Leeds, UK. S.L. Mackie declares consultancy to Roche, Chugai, and Sanofi on behalf of University of Leeds (no money paid to her directly in last 3 years); Patron of PMRGCAuk; current or recent site investigator on clinical trials for GSK and Sanofi; and EULAR2019 attendance supported by Roche. S. Muller is a trustee of PMRGCAuk. Address correspondence to Dr. H. Twohig, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK. Email: h.j.twohig@keele.ac.uk. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication July 13, 2020.
Caroline Mitchell
This work was supported by a Wellcome Trust PhD Programme for Primary Care Clinicians [203921/Z/16/Z], which supports Helen Twohig. CDM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHRRP- 2014-04-026). The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. 1H. Twohig, MRCP, MRCGP, S. Muller, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK; 2C. Owen, MBBS (Hons), FRACP, Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Melbourne, Australia; 3C.D. Mallen, FRCGP, PhD, S. Hider, FRCP, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, and Midlands Partnership Foundation Trust, Staffordshire, UK; 4C. Mitchell, FRCGP, MD, Academic Department of Primary Medical Care, University of Sheffield, Sheffield, UK; 5C. Hill, FRACP, MD, Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, and Discipline of Medicine, The University of Adelaide, Adelaide, Australia; 6B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 7S.L. Mackie, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Woodhouse, Leeds, UK. S.L. Mackie declares consultancy to Roche, Chugai, and Sanofi on behalf of University of Leeds (no money paid to her directly in last 3 years); Patron of PMRGCAuk; current or recent site investigator on clinical trials for GSK and Sanofi; and EULAR2019 attendance supported by Roche. S. Muller is a trustee of PMRGCAuk. Address correspondence to Dr. H. Twohig, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK. Email: h.j.twohig@keele.ac.uk. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication July 13, 2020.
Samantha Hider
This work was supported by a Wellcome Trust PhD Programme for Primary Care Clinicians [203921/Z/16/Z], which supports Helen Twohig. CDM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHRRP- 2014-04-026). The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. 1H. Twohig, MRCP, MRCGP, S. Muller, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK; 2C. Owen, MBBS (Hons), FRACP, Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Melbourne, Australia; 3C.D. Mallen, FRCGP, PhD, S. Hider, FRCP, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, and Midlands Partnership Foundation Trust, Staffordshire, UK; 4C. Mitchell, FRCGP, MD, Academic Department of Primary Medical Care, University of Sheffield, Sheffield, UK; 5C. Hill, FRACP, MD, Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, and Discipline of Medicine, The University of Adelaide, Adelaide, Australia; 6B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 7S.L. Mackie, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Woodhouse, Leeds, UK. S.L. Mackie declares consultancy to Roche, Chugai, and Sanofi on behalf of University of Leeds (no money paid to her directly in last 3 years); Patron of PMRGCAuk; current or recent site investigator on clinical trials for GSK and Sanofi; and EULAR2019 attendance supported by Roche. S. Muller is a trustee of PMRGCAuk. Address correspondence to Dr. H. Twohig, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK. Email: h.j.twohig@keele.ac.uk. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication July 13, 2020.
Catherine Hill
This work was supported by a Wellcome Trust PhD Programme for Primary Care Clinicians [203921/Z/16/Z], which supports Helen Twohig. CDM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHRRP- 2014-04-026). The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. 1H. Twohig, MRCP, MRCGP, S. Muller, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK; 2C. Owen, MBBS (Hons), FRACP, Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Melbourne, Australia; 3C.D. Mallen, FRCGP, PhD, S. Hider, FRCP, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, and Midlands Partnership Foundation Trust, Staffordshire, UK; 4C. Mitchell, FRCGP, MD, Academic Department of Primary Medical Care, University of Sheffield, Sheffield, UK; 5C. Hill, FRACP, MD, Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, and Discipline of Medicine, The University of Adelaide, Adelaide, Australia; 6B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 7S.L. Mackie, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Woodhouse, Leeds, UK. S.L. Mackie declares consultancy to Roche, Chugai, and Sanofi on behalf of University of Leeds (no money paid to her directly in last 3 years); Patron of PMRGCAuk; current or recent site investigator on clinical trials for GSK and Sanofi; and EULAR2019 attendance supported by Roche. S. Muller is a trustee of PMRGCAuk. Address correspondence to Dr. H. Twohig, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK. Email: h.j.twohig@keele.ac.uk. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication July 13, 2020.
Beverley Shea
This work was supported by a Wellcome Trust PhD Programme for Primary Care Clinicians [203921/Z/16/Z], which supports Helen Twohig. CDM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHRRP- 2014-04-026). The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. 1H. Twohig, MRCP, MRCGP, S. Muller, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK; 2C. Owen, MBBS (Hons), FRACP, Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Melbourne, Australia; 3C.D. Mallen, FRCGP, PhD, S. Hider, FRCP, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, and Midlands Partnership Foundation Trust, Staffordshire, UK; 4C. Mitchell, FRCGP, MD, Academic Department of Primary Medical Care, University of Sheffield, Sheffield, UK; 5C. Hill, FRACP, MD, Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, and Discipline of Medicine, The University of Adelaide, Adelaide, Australia; 6B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 7S.L. Mackie, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Woodhouse, Leeds, UK. S.L. Mackie declares consultancy to Roche, Chugai, and Sanofi on behalf of University of Leeds (no money paid to her directly in last 3 years); Patron of PMRGCAuk; current or recent site investigator on clinical trials for GSK and Sanofi; and EULAR2019 attendance supported by Roche. S. Muller is a trustee of PMRGCAuk. Address correspondence to Dr. H. Twohig, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK. Email: h.j.twohig@keele.ac.uk. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication July 13, 2020.
Sarah Mackie
This work was supported by a Wellcome Trust PhD Programme for Primary Care Clinicians [203921/Z/16/Z], which supports Helen Twohig. CDM is funded by the National Institute for Health Research (NIHR) Applied Research Collaboration West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHRRP- 2014-04-026). The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. 1H. Twohig, MRCP, MRCGP, S. Muller, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK; 2C. Owen, MBBS (Hons), FRACP, Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Melbourne, Australia; 3C.D. Mallen, FRCGP, PhD, S. Hider, FRCP, PhD, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, and Midlands Partnership Foundation Trust, Staffordshire, UK; 4C. Mitchell, FRCGP, MD, Academic Department of Primary Medical Care, University of Sheffield, Sheffield, UK; 5C. Hill, FRACP, MD, Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, and Discipline of Medicine, The University of Adelaide, Adelaide, Australia; 6B. Shea, PhD, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada; 7S.L. Mackie, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Woodhouse, Leeds, UK. S.L. Mackie declares consultancy to Roche, Chugai, and Sanofi on behalf of University of Leeds (no money paid to her directly in last 3 years); Patron of PMRGCAuk; current or recent site investigator on clinical trials for GSK and Sanofi; and EULAR2019 attendance supported by Roche. S. Muller is a trustee of PMRGCAuk. Address correspondence to Dr. H. Twohig, Primary Care Centre Versus Arthritis, School of Primary, Community and Social Care, Keele University, Staffordshire, UK. Email: h.j.twohig@keele.ac.uk. Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication July 13, 2020.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review
Helen Twohig, Claire Owen, Sara Muller, Christian D. Mallen, Caroline Mitchell, Samantha Hider, Catherine Hill, Beverley Shea, Sarah Mackie
The Journal of Rheumatology Aug 2020, jrheum.200248; DOI: 10.3899/jrheum.200248
Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review
Helen Twohig, Claire Owen, Sara Muller, Christian D. Mallen, Caroline Mitchell, Samantha Hider, Catherine Hill, Beverley Shea, Sarah Mackie
The Journal of Rheumatology Aug 2020, jrheum.200248; DOI: 10.3899/jrheum.200248